Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20503205 | 0.93 | FAAH (0.34) | ALDH1A1GAAMAPTTHRB | |
| SCHEMBL20503177 | 0.88 | POLB (0.30) | GAA | |
| SCHEMBL20503180 | 0.82 | FAAH (0.36) | ALDH1A1GAAMAPTTHRBKDM4E | |
| SCHEMBL20503174 | 0.79 | POLB (0.32) | GAA | |
| SCHEMBL5847509 | 0.76 | FAAH (0.39) | ALDH1A1GAAMAPTTHRB | |
| SCHEMBL3626814 | 0.74 | MGLL (0.41) | ALDH1A1GAAMAPTTHRB | |
| SCHEMBL10794655 | 0.74 | MGLL (0.41) | ALDH1A1GAAMAPTTHRB | |
| SCHEMBL10931031 | 0.74 | MGLL (0.41) | ALDH1A1GAAMAPTTHRB | |
| SCHEMBL28489550 | 0.74 | MGLL (0.41) | ALDH1A1GAAMAPTTHRB | |
| SCHEMBL145410 | 0.74 | KDM4E (0.35) | ALDH1A1GAAMAPTTHRBKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11548910-B2 | Oligonucleotide production method | NISSAN CHEMICAL CORPORATION (JP) | 2023-01-10 | — | — | US | disclosed |
| US-20190169223-A1 | OLIGONUCLEOTIDE PRODUCTION METHOD | NISSAN CHEMICAL CORPORATION (JP) | 2019-06-06 | — | — | US | disclosed |
| EP-3378869-A1 | METHOD FOR PRODUCING OLIGONUCLEOTIDE | Nissan Chemical Corporation (JP) | 2018-09-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11548910-B2 | Oligonucleotide production method | RNGTT, OSGEP, PHAX | ALDH1A1 3610/4885GAA 1813/4885MAPT 3183/4885 |
| US-20190169223-A1 | OLIGONUCLEOTIDE PRODUCTION METHOD | RNGTT, OSGEP, PHAX | ALDH1A1 3610/4885GAA 1813/4885MAPT 3183/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.